A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
/in Dendritic Cells, International PublicationsA pilot study of the impact of Vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients
/in International Publications, MicronutrientsThe Role of the Status of Selected Micronutrients in Shaping the Immune Function
/in International Publications, MicronutrientsModulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study
/in Glioblastoma, Hyperthermia, International PublicationsFrom chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
/in International Publications, IOZK VeröffentlichungenCombination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, International PublicationsImmunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables
/in Dendritic Cells, Glioblastoma, International PublicationsImmunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
/in Acute Leukemia, Dendritic Cells, International PublicationsAutologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study
/in Dendritic Cells, Gastric Cancer, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer